Ann‐Kathrin Eisfeld

Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: <i>miR-155</i> Upregulation Independently Identifies High-Risk Patients

Guido Marcucci, Kati Maharry, Klaus H. Metzeler et al. · Journal of Clinical Oncology · 2013 · 182 citations · Full text

Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias

Christopher J. Walker, Joshua J. Oaks, Ramasamy Santhanam et al. · Blood · 2013 · 145 citations · Full text

An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

Audrey Lasry, Bettina Nadorp, Maarten Fornerod et al. · Nature Cancer · 2022 · 139 citations · Full text

Inflammation, Hematological Malignancy, Immune Evasion +12

Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission

Sumithira Vasu, Jessica Kohlschmidt, Krzysztof Mrózek et al. · Blood Advances · 2018 · 105 citations · Full text

Dabrafenib Versus Dabrafenib + Trametinib in <i>BRAF</i> -Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial

Naifa L. Busaidy, Bhavana Konda, Lai Wei et al. · Thyroid · 2022 · 98 citations · Full text